The Case for Investing in OT(S)EIS
The Case for Investing in OT(S)EIS has been updated with figures to April 2019. You can read it at http://bit.ly/2leSM8N.
28th May 2019
Lupe launched on Kickstarter
Portfolio Company, Lupe, launched its Kickstarter Campaign on Tuesday. You can view the campaign, and be one of the first to buy the powerful, enduring, flexible vacuum cleaner at http://kck.st/30RyUQ8 OT(S)EIS invested in Lupe when it first started in 2017, and it is now going into manufacture with what it hopes will be the world’s best vacuum cleaner.
18th April 2019
OT China office has moved
Our office in Shanghai has now moved to a co-working space. Chenjie will continue to help our portfolio companies find opportunities in China.
15th April 2019
OT(S)EIS April Quarterly Report now available
The quarterly report to 5th April 2019 is now available. OT(S)EIS had completed 126 investments in 39 companies. In June 2016 OT(S)EIS invested £75,000 as an SEIS investment in Animal Dynamics at 14p per share, so 7p per share after tax relief. In March 2019, investors who had opted to sell their shares in Animal Dynamics received payment of 97p per share, so approximately 14 x the after tax share price. Other investors opted to keep their shares. The company is doing well.
22nd January 2019
Latest OT(S)EIS Quarterly Report published
The quarterly report to December 2018 is now available at this link. By 31st December 2018, OT(S)EIS had completed 105 investments in 34 companies, and things continue to go well.
10th December 2018
Expend in The Top 100
Expend were profiled in Syndicate Room's The Top 100, which ranks the fastest-growing businesses in the UK. In the article, Johnny Vowles (CEO) wrote "Our current investors... have been great because they understand what we are trying to achieve and the route we have to take to get there. Many investors have been supportive in other ways beyond simply a funding perspective."
9th November 2018
Lightpoint Medical achieve ISO 13485
Lightpoint Medical is proud to announce that the company has achieved ISO13485:2016 certification awarded by TÜV SÜD. The certification reflects the company's commitment to the highest level of medical device quality control.13th September 2018
Active Needle win Innovate UK award
Active Needle are very pleased to have won an Innovate UK award with Xerion Healthcare to develop a high-performance system for a new radiotherapy enhancing treatment.5th August 2018
Molecular Warehouse reach fundraising target
Our portfolio company, Molecular Warehouse, reached their fundraising target of £750,000 on Syndicate Room, with a pre-money valuation of over £12 million. After our initial investment in April 2015, Oxford Technology have made four more follow-on investments, and continue to support them and fund raise for them through our network.5th August 2018
Animal Dynamics on Radio 2
Adrian Thomas of Animal Dynamics joined Chris Evans on The Breakfast Show on BBC Radio 2 to talk about bumblebee flight. Listen here.25th July 2018
Lightpoint Medical shortlisted for National Business Awards
Lightpoint Medical was named a Finalist in The Lloyds Bank National Business Awards, which will be held on the 13th November 2018. "The National Business Awards gives companies the chance to tell their success story to a national audience, regardless of size or industry, through the UK's most prestigious awards programme. [They] celebrate and reward true excellence in business and go beyond best practice, awarding the work that combines creativity and innovation with effectiveness - setting new standards for the industry."19th July 2018
Animal Dynamics announce their partnership with dstl
Animal Dynamics are very happy to announce that they are working with dstl to develop Stork, the autonomous logistics vehicle. The announcement was covered in the Financial Times article: UK trials unmanned systems to supply troops on the front line.5th July 2018
Technology behind Arago Biosciences explained in Nature Methods
The technology which forms the base for our newest portfolio company, Arago Biosciences, has been published in Nature Methods: Weighing single proteins with light. The technology is "likely to enable numerous biophysical experiments".28th June 2018
Expend in the FT
Our portfolio company, Expend were quoted in the Financial Times article Rich People’s Problems: The trouble with expenses claims.29th May 2018
Sime Diagnostics feature on Microsoft for Startups blog
Our portfolio company, Sime Diagnostics were featured on the Microsoft for Start-ups blog with an article about How Machine Learning will Transform Care for Millions of Premature Babies in China.25th May 2018
Creative England recognise Covatic in CE50
Investee company, Covatic were recognised by Creative England as one of the 50 most exciting, innovative and disruptive creative companies in the UK. See the full list of creative leaders of tomorrow at CE50 2018.29th March 2018
Oxford Technology office in China
Oxford Technology has opened an office in Shanghai. Chenjie, who has a degree in engineering from Oxford University and who worked for OTM in Oxford before moving to China in 2017, is currently helping various Oxford Technology investees to get their technologies adopted in China, and also helping these companies to raise capital from Chinese investors. She is currently acting as the interim CEO for Sime, China. Sime has a technology for improving the outcome for premature babies with breathing difficulties. This is a big problem in China where the technology is being enthusiastically welcomed.
28th March 2018
Covatic in Creative Industries Sector Deal
Our portfolio company, Covatic, were listed as example of "innovation... at the intersection of creativity and technology" on page 31 of the government's Creative Industries Sector Deal.11 December 2017
Designer Carbon Materials' Breakthrough in Chemical Communications
Kyriakos and his team managed to functionalise N@C60 in such a way that it became water soluble. This was a major achievement and was published in the leading journal Chemical Communications with a picture on the front cover. This means that N@C60 can now be used in fluids including in blood. N@C60 on its own exhibits a very sharp EPR (Electron Paramagnetic Resonance) peak. But in the presence of oxygen this peak broadens, and the amount of broadening is proportional to the oxygen concentration. This provides a means of determining the oxygen concentration in cells. Cancer cells have a lower oxygen content than healthy cells. So this is a potential method of helping the detection of cancer.2nd November 2016
Oxford Technology Management Wins Best SEIS & EIS Fund Award
Wealth and Finance International's 2016 Fund Awards press release announced that Oxford Technology Management is the Winner of the UK's Best SEIS & EIS Fund Award.8th September 2016
Oxford Technology hosts Showcase
An event here in the Oxford Science Park where four of our investee companies will give short presentations so that our investors and anyone else who is interested can meet the founders. All those interested in Oxford Start-Ups are welcome to attend.18th April 2016
Lucius interviewed in Master Investor
Lucius was interviewed by Master Investor for their article Oxford Technology: Tapping into the UK’s Centres of Excellence.20th October 2015
Lightpoint Medical in the news
Lightpoint Medical, an investee company from the OT(S)EIS fund, has received CE approval for its LightPath imaging system. Read more about it in this News-Medical article7th September 2015
Animal Dynamics in the news
One of OT(S)EIS's investee companies, Animal Dynamics, has been featured in the Economist. Read about it in the article "Flapping About - Biomechanics: Replacing a propeller with a flapping fin could help a team of zoologists set a new speed record on the water"